000 01298 a2200337 4500
005 20250517010146.0
264 0 _c20150724
008 201507s 0 0 eng d
022 _a1463-1318
024 7 _a10.1111/codi.12817
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPrincipi, M
245 0 0 _aPrevention of colorectal adenomas.
_h[electronic resource]
260 _bColorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland
_cJan 2015
300 _a20-4 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdenoma
_xmetabolism
650 0 4 _aAspirin
_xtherapeutic use
650 0 4 _aColorectal Neoplasms
_xmetabolism
650 0 4 _aEstrogen Receptor alpha
_xmetabolism
650 0 4 _aEstrogen Receptor beta
_xmetabolism
650 0 4 _aHumans
650 0 4 _aLigands
650 0 4 _aLignin
_xtherapeutic use
650 0 4 _aMetformin
_xtherapeutic use
650 0 4 _aPhytoestrogens
_xtherapeutic use
650 0 4 _aSilymarin
_xtherapeutic use
700 1 _aDe Censi, A
773 0 _tColorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland
_gvol. 17 Suppl 1
_gp. 20-4
856 4 0 _uhttps://doi.org/10.1111/codi.12817
_zAvailable from publisher's website
999 _c24461782
_d24461782